460 related articles for article (PubMed ID: 33247690)
21. LAMC2 is a predictive marker for the malignant progression of leukoplakia.
Nguyen CT; Okamura T; Morita KI; Yamaguchi S; Harada H; Miki Y; Izumo T; Kayamori K; Yamaguchi A; Sakamoto K
J Oral Pathol Med; 2017 Mar; 46(3):223-231. PubMed ID: 27529842
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
24. Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: an immunohistochemical study.
Varghese SS; Sunil PM; Madhavan RN
Cancer Biomark; 2010-2011; 8(3):155-60. PubMed ID: 22012771
[TBL] [Abstract][Full Text] [Related]
25. HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma.
Fernández-Valle Á; Rodrigo JP; Rodríguez-Santamarta T; Villaronga MÁ; Álvarez-Teijeiro S; García-Pedrero JM; Suárez-Fernández L; Lequerica-Fernández P; de Vicente JC
Head Neck; 2016 Nov; 38(11):1672-1678. PubMed ID: 27131339
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma.
Ma HL; Jin SF; Tao WJ; Zhang ML; Zhang ZY
J Craniomaxillofac Surg; 2016 Oct; 44(10):1725-1732. PubMed ID: 27591090
[TBL] [Abstract][Full Text] [Related]
27. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
28. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW
Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of survivin expression in leukoplakia, lichen planus, and oral squamous cell carcinoma: An immunohistochemical study.
Angelin D; Nair BJ
J Cancer Res Ther; 2020; 16(3):569-574. PubMed ID: 32719269
[TBL] [Abstract][Full Text] [Related]
31. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
Zhang J; Zeng Y; Zheng J; Xu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
[TBL] [Abstract][Full Text] [Related]
32. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
33. Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma.
Kobayashi H; Sagara J; Masumoto J; Kurita H; Kurashina K; Taniguchi S
J Oral Pathol Med; 2003 Jul; 32(6):344-9. PubMed ID: 12787041
[TBL] [Abstract][Full Text] [Related]
34. [Clinical importance of microtubule-associated protein 1 light chain 3 and mammalian target of rapamycin expression in oral leukoplakia and oral squamous cell carcinoma].
Dong XL; Liu ZW
Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Dec; 36(6):613-618. PubMed ID: 30593105
[TBL] [Abstract][Full Text] [Related]
35. Role of E-cadherin in Progression of Oral Squamous Cell Carcinoma: A Retrospective Immunohistochemical Study.
Gupta A; Sharma S; Batra M; Abidullah M; Bhuvinder S; Katragadda P
J Contemp Dent Pract; 2018 Sep; 19(9):1105-1110. PubMed ID: 30287712
[TBL] [Abstract][Full Text] [Related]
36. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
37. [Expression of survivin, caspase-3 in oral precancerous lesions and oral squamous-cell carcinoma].
Ding YP; Li SX; Wu HR; Zhang XY; Tang XF; Sun Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):85-8. PubMed ID: 20368001
[TBL] [Abstract][Full Text] [Related]
38. Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study.
Pontes HA; de Aquino Xavier FC; da Silva TS; Fonseca FP; Paiva HB; Pontes FS; dos Santos Pinto D
J Oral Pathol Med; 2009 Sep; 38(8):644-50. PubMed ID: 19453843
[TBL] [Abstract][Full Text] [Related]
39. Computer aided morphometric analysis of oral leukoplakia and oral squamous cell carcinoma.
Gupta K; Gupta J; Miglani R
Biotech Histochem; 2016; 91(4):251-4. PubMed ID: 26983454
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
Nanda KD; Ranganathan K; Devi U; Joshua E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
